Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 296,133	$ 88,415
Other receivable	2,880	2,880
Other assets	197,980	52,686
Total current assets	496,993	143,981
Long-term assets
Long-term receivable	582,377	582,377
Property and equipment - net	32,292	36,568
Deferred compensation	1,875,000	2,083,334
Total long-term assets	2,489,669	2,702,279
TOTAL ASSETS	2,986,662	2,846,260
Current liabilities
Accounts payable	298,522	472,868
Accrued officer compensation	206,000	206,000
Notes payable including accrued interest of $176,423 at March 31, 2020 and $119,218 at December 31, 2019	3,513,591	3,467,890
Due to related parties	50,000	50,000
Accrued expenses	3,020	23,587
Accrued dividends	48,079	48,079
Total current liabilities	4,119,212	4,268,424
Long-term liabilities
Long-term notes payable	1,500,000	1,500,000
Total liabilities	5,619,212	5,768,424
Commitments and contingencies
Stockholders' (deficit)
Series A Convertible Preferred Stock, $.001 par value, 2,000,000 shares authorized; 13,602 shares issued and outstanding at March 31, 2020 and at December 31, 2019	14	14
Common stock, $.001 par value, 500,000,000 shares authorized; 210,304,062 and 206,569,062 shares issued and outstanding at March 31, 2020 and at December 31, 2019, respectively	210,304	206,569
Additional paid-in capital	87,458,494	85,907,523
Accumulated deficit	(90,301,362)	(89,036,270)
Total stockholders' (deficit)	(2,632,550)	(2,922,164)
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT)	$ 2,986,662	$ 2,846,260